Chonluten

Moderate Research

Tripeptide bioregulator

Chonluten is a tripeptide bioregulator that has been studied in immunology research for its effects on immune tissue gene expression. Published research has investigated its role in thymic and immune tissue regulation. RaysunPeptide supplies Chonluten for qualified research and laboratory applications.

Mechanism of Action

Chonluten works through epigenetic regulation, penetrating cell and nuclear membranes to bind promoter or suppressor regions of DNA and modulate transcriptional control. It regulates genes including c-Fos, HSP70 (heat-shock protein), SOD (superoxide dismutase), COX-2, and TNF-alpha related to oxidative stress and proliferative regulation. The peptide inhibits TNF production in monocytes exposed to pro-inflammatory LPS, promoting attenuation of inflammatory action through TNF tolerance mechanisms.

Key Benefits

1Normalizes respiratory system function
2Regulates protein synthesis in lung tissue
3Inhibits inflammatory TNF production
4Restores lung alveolar tissues
5Maintains bronchial mucous membranes
6Supports antioxidant gene expression
7May slow cell aging (geroprotective)
8Modulates mucosal function

Molecular Data

Molecular Weight
319 Da
Half-Life
Minutes (short peptide); effects persist via epigenetic changes
Chain Length
3 amino acids
Amino Acid Sequence
EDG

Dosing Protocols

GoalDoseFrequencyRoute
Standard protocol10-20 mgDaily for 10-20 daysOral capsules
Maintenance10 mg2-3 cycles yearlyOral capsules

Research Indications

Respiratory Support

Bronchial Functioneffective

Normalizes respiratory system function through gene expression regulation.

Lung Tissue Healtheffective

Restores and maintains lung alveolar tissues and bronchial mucous membranes.

COPD Supportmoderate

May modulate mucosal function in chronic obstructive pulmonary disease.

Anti-Inflammatory

TNF Modulationeffective

Inhibits TNF production in monocytes, reducing inflammatory responses.

Oxidative Stressmoderate

Supports SOD and antioxidant gene expression.

Anti-Aging

Geroprotectionmoderate

Researched as potential agent that may slow cell aging.

Gene Expression Regulationmoderate

Modulates c-Fos and proliferative gene activity.

Peptide Interactions

Bronchogen++ synergistic

Related respiratory bioregulators; complementary mechanisms.

Epitalon++ synergistic

Often combined in comprehensive anti-aging Khavinson protocols.

Crystagen+ compatible

Both have immune-modulating properties; different tissue targets.

BPC-157+ compatible

Both support mucosal health through different mechanisms.

What to Expect

1
During cycle
Gene expression modulation and anti-inflammatory effects begin
2
Post-cycle
Effects persist due to epigenetic changes
3
Weeks-Months
Respiratory function improvements
4
Long-term
Cumulative benefits with periodic cycles

Side Effects & Safety

Common (Generally Mild)

  • •Generally well-tolerated
  • •Minimal side effects reported

Stop Signs (Seek Medical Attention)

  • ⚠Allergic reactions
  • ⚠Unusual respiratory symptoms

Contraindications

  • ✕Active respiratory emergencies (seek medical care)
  • ✕Known hypersensitivity
  • ✕Pregnancy or breastfeeding

Quality Checklist

Good Signs ✓

  • White powder or capsules
  • Clear solution if reconstituted
  • Proper packaging and labeling

Warning Signs !

  • Unknown source or purity

Bad Signs ✕

  • Discoloration
  • Unusual odor
  • Damaged packaging

References

Peptides Regulating Proliferative Activity and Inflammatory Pathways in THP-1 Cells
• PMC/NCBI • 2022

Chonluten tripeptide inhibits TNF production in monocytes exposed to pro-inflammatory LPS.

Chonluten and Gene Expression Regulation
• Advances in Gerontology • 2018

Chonluten regulates c-Fos, HSP70, SOD, COX-2, and TNF-alpha gene expression.

Bronchial Bioregulator Peptides
• Bulletin of Experimental Biology and Medicine • 2016

Short peptides derived from bronchial tissue regulate protein synthesis in lung cells.

Khavinson Peptide Bioregulators
• Advances in Gerontology • 2020

Comprehensive review of bioregulator peptides including Chonluten and their mechanisms.

FAQs

Can Chonluten be taken orally or must it be injected?

Chonluten is available in multiple forms including oral capsules, sublingual, and injectable routes. As a short tripeptide, it has favorable absorption when taken orally (10-20mg daily) or sublingually for enhanced absorption. Most commonly used as a 10-20 day oral cycle, though injectable forms bypass GI metabolism for direct delivery.

How often should Chonluten cycles be repeated?

Standard protocol involves 10-20 day cycles repeated 2-3 times per year with breaks in between. After completing a cycle, effects persist for weeks due to epigenetic changes in gene expression, so spacing cycles allows the body to maintain benefits while avoiding habituation.

Does Chonluten help with chronic respiratory issues like COPD?

Research shows Chonluten has moderate effectiveness for COPD support through TNF inhibition and restoration of lung alveolar tissues. It normalizes respiratory function through gene expression regulation, though it works best as a preventative and maintenance therapy rather than an acute treatment for active respiratory emergencies.

What makes Chonluten different from other immune-supporting peptides?

Chonluten is specifically derived from bronchial lung tissue and targets the respiratory system primarily, unlike broad immune peptides. It regulates genes like c-Fos, HSP70, SOD, and TNF-alpha to reduce inflammatory responses and support lung tissue health, making it unique for respiratory-specific immune modulation.

Chonluten

Dosing Summary

Dose
10-20 mg daily
Frequency
Once daily for 10-20 consecutive days
Cycle
10-20 days per cycle
Storage
Capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated

Specifications

Purity≥98% (HPLC verified)
FormLyophilized powder
Packaging20mg
StorageStore at -20°C, protect from light
Catalog No.CH20

Research Data

4
Studies
2022
Latest
0
Recent

Available Sizes

20mg$30